BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23909911)

  • 1. Concordance of retinopathy and nephropathy over time in Type 1 diabetes: an analysis of data from the Diabetes Control and Complications Trial.
    Kramer CK; Retnakaran R
    Diabet Med; 2013 Nov; 30(11):1333-41. PubMed ID: 23909911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoacidosis at diagnosis in childhood-onset diabetes and the risk of retinopathy 20years later.
    Salardi S; Porta M; Maltoni G; Cerutti F; Rovere S; Iafusco D; Tumini S; Cauvin V; Zucchini S; Cadario F; dʾAnnunzio G; Toni S; Salvatoni A; Zedda MA; Schiaffini R;
    J Diabetes Complications; 2016; 30(1):55-60. PubMed ID: 26598223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unchanged incidence of severe retinopathy in a population of Type 1 diabetic patients with marked reduction of nephropathy.
    Bojestig M; Arnqvist HJ; Karlberg BE; Ludvigsson J
    Diabet Med; 1998 Oct; 15(10):863-9. PubMed ID: 9796888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes; 1997 Nov; 46(11):1829-39. PubMed ID: 9356033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.
    Wadén J; Forsblom C; Thorn LM; Saraheimo M; Rosengård-Bärlund M; Heikkilä O; Hietala K; Ong K; Wareham N; Groop PH;
    Diabetes; 2009 Aug; 58(8):1914-20. PubMed ID: 19491208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plantar fascia thickness is longitudinally associated with retinopathy and renal dysfunction: a prospective study from adolescence to adulthood.
    Benitez-Aguirre PZ; Craig ME; Jenkins AJ; Gallego PH; Cusumano J; Duffin AC; Hing S; Donaghue KC
    J Diabetes Sci Technol; 2012 Mar; 6(2):348-55. PubMed ID: 22538146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
    ; Lachin JM; Genuth S; Cleary P; Davis MD; Nathan DM
    N Engl J Med; 2000 Feb; 342(6):381-9. PubMed ID: 10666428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HbA
    Lind M; Pivodic A; Svensson AM; Ólafsdóttir AF; Wedel H; Ludvigsson J
    BMJ; 2019 Aug; 366():l4894. PubMed ID: 31462492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between diabetic retinopathy, microalbuminuria and overt nephropathy, and twenty-year incidence follow-up of a sample of type 1 diabetic patients.
    Romero-Aroca P; Baget-Bernaldiz M; Reyes-Torres J; Fernandez-Ballart J; Plana-Gil N; Mendez-Marin I; Pareja-Rios A
    J Diabetes Complications; 2012; 26(6):506-12. PubMed ID: 22921286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The temporal development of retinopathy and nephropathy in type 1 diabetes mellitus during 15 years diabetes duration.
    Lövestam-Adrian M; Agardh E; Agardh CD
    Diabetes Res Clin Pract; 1999 Aug; 45(1):15-23. PubMed ID: 10499881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
    Huang JX; Liao YF; Li YM
    Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes.
    Olsen BS; Sjølie AK; Hougaard P; Johannesen J; Marinelli K; Jacobsen BB; Mortensen HB;
    J Diabetes Complications; 2004; 18(3):160-4. PubMed ID: 15145327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-normal urinary albumin concentrations predict progression to diabetic nephropathy in Type 1 diabetes mellitus.
    Royal College of Physicians of Edinburgh Diabetes Register Group.
    Diabet Med; 2000 Nov; 17(11):782-91. PubMed ID: 11131103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study.
    Lloyd CE; Klein R; Maser RE; Kuller LH; Becker DJ; Orchard TJ
    J Diabetes Complications; 1995; 9(3):140-8. PubMed ID: 7548977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study.
    Gallego PH; Craig ME; Hing S; Donaghue KC
    BMJ; 2008 Aug; 337():a918. PubMed ID: 18728082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age at menarche and the risk of diabetic microvascular complications in patients with type 1 diabetes.
    Harjutsalo V; Maric-Bilkan C; Forsblom C; Groop PH;
    Diabetologia; 2016 Mar; 59(3):472-80. PubMed ID: 26607636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.
    Svensson MK; Tyrberg M; Nyström L; Arnqvist HJ; Bolinder J; Östman J; Gudbjörnsdottir S; Landin-Olsson M; Eriksson JW
    Diabetes Metab Res Rev; 2015 Feb; 31(2):138-46. PubMed ID: 25044633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.